Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

The Impact of Anti-HLA Antibodies on the Prognosis of Allogeneic Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndrome

Tiantian Xie, Runqing Lu, Weijie Cao, Bian Zhilei, Wei Li, Zhongxing Jiang, Yongping Song, Dengju Li, Rong Guo

Blood (2024) 144 (Supplement 1): 7419.

https://doi.org/10.1182/blood-2024-206974

Published: 2024

Journal Articles

Preliminary Results of a Phase 2 Study of IMM01 Combined with Azacitidine (AZA) As the First-Line Treatment in Adult Patients with Higher Risk Myelodysplastic Syndromes (MDS)

Blood (2023) 142 (Supplement 1): 320.

https://doi.org/10.1182/blood-2023-174420

Published: 2023

Journal Articles

Trial in Progress: A Perspective Study of Pan-Oral Triplet Regimen Pomalidomide, Ixazomib and Dexamethasone in Relapsed or Refractory Myeloma Patients

Miao Chen, Li Bao, Wenming Chen, Rong Fu, Rong Guo, Hongmei Jing, Hui Liu, Qinhua Liu, Yanping Ma, Xiuli SUN, Wei Wang, Yafei Wang, Xiaojing Yan, Jiang Qian, Junling Zhuang

Blood (2021) 138 (Supplement 1): 4783.

https://doi.org/10.1182/blood-2021-148237

Published: 2021

Journal Articles

A Clinical Study of Bone Marrow Stromal Cell Therapy in Patients with Refractory Cgvhd by Down-Regulating the Jagged2 Gene

Jianyu Weng, MD, Xin Huang, Suxia Geng, Chengwei Luo, Suijing Wu, Wei Ling, Rong Guo, Zesheng Lu, Chengxin Deng, Pengxiang Andy, Xin Du

Blood (2012) 120 (21): 4673.

https://doi.org/10.1182/blood.V120.21.4673.4673

Published: 2012

Journal Articles

Long Term Follow-up of Allogeneic Transplantation Using BEAM Chemotherapy for Patients with Hodgkin's Lymphoma Who Relapse After Autologous Transplantation: Importance of Minimal Residual Disease At Transplant.

Urszula A Sobol, MD, Tulio E. Rodriguez, MD, Scott E. Smith, MD, PhD, Aileen Go, MD, Ross Vimr, MD, Mala Parthasarathy, MS, Rong Guo, MS, Patrick Stiff, MD

Blood (2012) 120 (21): 3131.

https://doi.org/10.1182/blood.V120.21.3131.3131

Published: 2012

Journal Articles

Cardiac Complications Following Allogeneic Bone Marrow Transplantation: Evaluation of Risk Factors, Outcomes and Enhanced Screening for At Risk Populations.

Michael Henry, BS, Rong Guo, MS, Mala Parthasarathy, MS, John Lopez, MD, Patrick Stiff, MD

Blood (2012) 120 (21): 3070.

https://doi.org/10.1182/blood.V120.21.3070.3070

Published: 2012

Journal Articles

Selective Targeting of B Cells with Mesenchymal Stromal Cells Treatment Is An Efficacious Strategy for Cutaneous Cgvhd,

Peilong Lai, Jianyu Weng, Chenwei Luo, Rong Guo, Zesheng Lu, Suxia Geng, Xin Du, PhD, Suijing Wu

Blood (2011) 118 (21): 4086.

https://doi.org/10.1182/blood.V118.21.4086.4086

Published: 2011

Journal Articles

Bortezomib Inhibit Acute Graft-Versus-Host Disease Via Shifting the Combination of T Cells Subpopulations

Jianyu Weng, Shaoze Lin, Peilong Lai, Meikun Lv, Xin Du, PhD, Wei Ling, Rong Guo, Chengwei Luo

Blood (2011) 118 (21): 4709.

https://doi.org/10.1182/blood.V118.21.4709.4709

Published: 2011

Journal Articles

Expression and Clinical Significance of Antiapoptotic Gene Aven in De Novo acute Myeloid Leukemia Patients.

SuXia Geng, MD, Xin Du, PhD/MD, Jianyu Weng, MD, Liye Zhong, MD, Rong Guo, PhD, Zesheng Lu, MD, Suijing Wu, MD

Blood (2009) 114 (22): 4132.

https://doi.org/10.1182/blood.V114.22.4132.4132

Published: 2009

Journal Articles

Different Dosage of Bortezomib Impacts the Prevention of Acute Graft-Versus-Host Disease.

Jianyu Weng, MD, Meikun Lü, MD, Xin Du, PhD, Lin Xu, PhD, Suxia Geng, MD, Rong Guo, PhD, Suijin Wu, MD, Wei Ling, PhD, Yuchun Wang

Blood (2009) 114 (22): 4499.

https://doi.org/10.1182/blood.V114.22.4499.4499

Published: 2009

Journal Articles

Mesenchymal Stem Cells Relieve Chronic GVHD Via Modulation the Ratio of CD8+CD28-/CD8+CD28+T Cells.

Jianyu Weng, MD, Xin Du, PhD, Suxia Geng, MD, Maohua Zhou, MD, Yanwen Peng, Zhen Wang, Zesheng Lu, Suijing Wu, MD, Chenwei Luo, MD, Rong Guo, PhD, Wei Ling, PhD, Chengxin Deng, Pengjun Liao, Andy Peng Xiang, Ph.D

Blood (2009) 114 (22): 4501.

https://doi.org/10.1182/blood.V114.22.4501.4501

Published: 2009

Journal Articles

Distribution of Cytoskeleton Protein Nestin in Acute Leukemia.

Xin Du, PhD, Xuhui Yang, PhD, Wei Ling, PhD, Xia Tian, Maoxian Zou, Zhengguang Chen, Tao Wang, Jianyu Weng, MD, Suijing Wu, MD, Rong Guo, PhD, Xiuming Zhang, Bruce T. Lahn, Andy Peng Xiang, PhD

Blood (2009) 114 (22): 4721.

https://doi.org/10.1182/blood.V114.22.4721.4721

Published: 2009

Journal Articles

Analysis of TCR Vgamma and Vdelta Repertoire and Clonality of T Cells in MDS Patients.

SuXia Geng, MD, Xin Du, PhD, Yangqiu Li, PhD, Jianyu Weng, MD, Liye Zhong, MD, Suijing Wu, MD, Rong Guo, PhD, Zesheng Lu, MD

Blood (2009) 114 (22): 4833.

https://doi.org/10.1182/blood.V114.22.4833.4833

Published: 2009

Journal Articles

Analysis of the Immunophenotypic Features of Blast Cells, Lymphocytes and Granulocytes by Multiparametric Flow Cytometry in Bone Marrow (BM) Cells of Myelodysplastic Syndromes.

Xin Du, PhD, Jing Huang, MD, Maohua Zhou, MD, SuXia Geng, MD, Jianyu Weng, MD, Suijing Wu, MD, Rong Guo, PhD, Zesheng Lu, MD, Miaorong She, PhD

Blood (2009) 114 (22): 4843.

https://doi.org/10.1182/blood.V114.22.4843.4843

Published: 2009

Journal Articles

Using Multiparametric Flow Cytometry to Analysis the Immunophenotypic Abnormalities of Bone Marrow Cells in Patients with MDS-RAEB.

Jing Huang, MD, Xin Du, PhD, Suxia Geng, MD, Maohua Zhou, MD, Jianyu Weng, MD, Suijing Wu, MD, Rong Guo, PhD, Zesheng Lu, MD, Miaorong She, PhD

Blood (2009) 114 (22): 4856.

https://doi.org/10.1182/blood.V114.22.4856.4856

Published: 2009

Journal Articles

Fludarabine, Cytarabine, Busulphan, and Cyclophosphamide (FABC) as Conditioning Regimen in Hematopoietic Stem Cell Transplantation for Treatment of 92 Patients with Hematologic Malignancies.

Jianyu Weng, MD, Xin Du, PhD, Suijin Wu, MD, Zesheng Lu, MD, Chengwei Luo, MD, Rong Guo, PhD, Liye Zhong, MD, Miaorong She, PhD, Chengxin Deng, Wei Ling, PhD, Xiaoli Zou, Qunhua Li, Wei Lin, Zhixin Huang

Blood (2009) 114 (22): 1147.

https://doi.org/10.1182/blood.V114.22.1147.1147

Published: 2009

Journal Articles

Mesenchymal Stem Cells Derived from Different Donors as Salvage Therapy for Resistant Severe Acute Graft-Versus-Host Disease

Jianyu Weng, MD, Xin Du, PhD/MD, Peng Xiang, PhD, Suijin Wu, MD, Zesheng Lu, MD, Chengwei Luo, MD, Rong Guo, MD, Wei Ling, MD

Blood (2008) 112 (11): 4364.

https://doi.org/10.1182/blood.V112.11.4364.4364

Published: 2008

Journal Articles

Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-Versus-Host Disease.

Weng Jianyu, MD, Xin Du, MD, PhD, Xiang Peng, MD, Zhang Xiumin, MD, Suijin Wu, MD, Zesheng Lu, MD, Chengwei Luo, MD, Rong Guo, MD, Chengxin Deng, MD, Wei Ling, MD, Wei Lin, MD, Zilun Huang, MD

Blood (2007) 110 (11): 4968.

https://doi.org/10.1182/blood.V110.11.4968.4968

Published: 2007

Journal Articles

A Pilot Study of Mycophenolate Mofetil for the Prophylaxis and Treatment of Graft-Versus-Host Disease.

Chengwei Luo, MD, Xin Du, MD, PhD, Jianyu Weng, MD, Rong Guo, MD, Zesheng Lu, MD

Blood (2007) 110 (11): 4969.

https://doi.org/10.1182/blood.V110.11.4969.4969

Published: 2007

Journal Articles

Analysis T Cell Receptor Excision Circles (TRECs) in Patients with Graft-Versus-Host Disease (GVHD) after Allogeneic Stem Cell Transplantation.

Xin Du, MD, PhD, Yangqiu Li, MD, Jianyu Weng, MD, Zesheng Lu, MD, Rong Guo, MD, Shaohua Chen, MD, Lijian Yang, MD, Suxia Geng, MD, Zhilun Huang, MD

Blood (2006) 108 (11): 5272.

https://doi.org/10.1182/blood.V108.11.5272.5272

Published: 2006

NARROW

The Impact of Anti-HLA Antibodies on the Prognosis of Allogeneic Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndrome

Preliminary Results of a Phase 2 Study of IMM01 Combined with Azacitidine (AZA) As the First-Line Treatment in Adult Patients with Higher Risk Myelodysplastic Syndromes (MDS)

Trial in Progress: A Perspective Study of Pan-Oral Triplet Regimen Pomalidomide, Ixazomib and Dexamethasone in Relapsed or Refractory Myeloma Patients

A Clinical Study of Bone Marrow Stromal Cell Therapy in Patients with Refractory Cgvhd by Down-Regulating the Jagged2 Gene

Long Term Follow-up of Allogeneic Transplantation Using BEAM Chemotherapy for Patients with Hodgkin's Lymphoma Who Relapse After Autologous Transplantation: Importance of Minimal Residual Disease At Transplant.

Cardiac Complications Following Allogeneic Bone Marrow Transplantation: Evaluation of Risk Factors, Outcomes and Enhanced Screening for At Risk Populations.

Selective Targeting of B Cells with Mesenchymal Stromal Cells Treatment Is An Efficacious Strategy for Cutaneous Cgvhd,

Bortezomib Inhibit Acute Graft-Versus-Host Disease Via Shifting the Combination of T Cells Subpopulations

Expression and Clinical Significance of Antiapoptotic Gene Aven in De Novo acute Myeloid Leukemia Patients.

Different Dosage of Bortezomib Impacts the Prevention of Acute Graft-Versus-Host Disease.

Mesenchymal Stem Cells Relieve Chronic GVHD Via Modulation the Ratio of CD8+CD28-/CD8+CD28+T Cells.

Distribution of Cytoskeleton Protein Nestin in Acute Leukemia.

Analysis of TCR Vgamma and Vdelta Repertoire and Clonality of T Cells in MDS Patients.

Analysis of the Immunophenotypic Features of Blast Cells, Lymphocytes and Granulocytes by Multiparametric Flow Cytometry in Bone Marrow (BM) Cells of Myelodysplastic Syndromes.

Using Multiparametric Flow Cytometry to Analysis the Immunophenotypic Abnormalities of Bone Marrow Cells in Patients with MDS-RAEB.

Fludarabine, Cytarabine, Busulphan, and Cyclophosphamide (FABC) as Conditioning Regimen in Hematopoietic Stem Cell Transplantation for Treatment of 92 Patients with Hematologic Malignancies.

Mesenchymal Stem Cells Derived from Different Donors as Salvage Therapy for Resistant Severe Acute Graft-Versus-Host Disease

Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-Versus-Host Disease.

A Pilot Study of Mycophenolate Mofetil for the Prophylaxis and Treatment of Graft-Versus-Host Disease.

Analysis T Cell Receptor Excision Circles (TRECs) in Patients with Graft-Versus-Host Disease (GVHD) after Allogeneic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only